Nurse Practitioner Program year 2024 Reported 2022–2024 Source: CMS Open Payments, 2026 publication

Angela Rhode

Nurse Practitioner Stevens Point, WI Nurse Practitioner

NPI 1750647368 CMS profile 10947965

824 Illinois Ave, Stevens Point, WI 54481

Open in the dashboard

General payments

$431

5 records reported · program years 2022–2024

Research payments

$0

Paid to them · None reported · program years 2022–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Angela Rhode of Stevens Point, WI is reported in the CMS Open Payments database as having received $431 across 5 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 54th percentile of Nurse Practitioner profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

2 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $393 2
2022 General $38 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Angela Rhode
  • Nurse Practitioner median
  • Middle half of Nurse Practitioner
  • National median

In program year 2025, general payments to Angela Rhode were reported at $0. Among 41,044 Nurse Practitioner profiles paid that year, the median was $174 and the middle half received between $55 and $557.

Show as a table
Year Angela Rhode Nurse Practitioner median Middle half National median
2019 $0 $50 $22–$97 $163
2020 $0 $40 $16–$108 $114
2021 $0 $135 $40–$426 $132
2022 $38 $152 $48–$470 $149
2023 $0 $166 $54–$529 $160
2024 $393 $173 $55–$556 $164
2025 $0 $174 $55–$557 $169

Breakdown

Who paid General payments · program years 2022–2024
  1. Integra LifeSciences Corporation $379 1 payment
  2. Smith+Nephew, Inc. $38 3 payments
  3. Urgo Medical North America, LLC $15 1 payment

Every payment, record by record

What the payments were for General payments · program years 2022–2024
  1. Long term medical supply or device loan $379 1 payment
  2. Food and Beverage $52 4 payments
Products named General payments · program years 2022–2024
  1. ACell $379 1 payment
  2. VASHE WOUND SOLUTION 250 ML (8.5 FL OZ) FLIP TOP CAP $15 1 payment
  3. STRAVIX $14 1 payment
  4. GRAFIX PL $12 1 payment
  5. STRAVIX MESH $12 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 11 drugs

Part D claims

179

Median for Nurse Practitioner: 389

Drug cost

$8,881

Median for Nurse Practitioner: $21,885

Branded share of claims

26.3%

Median for Nurse Practitioner: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Santyl Collagenase Clostridium Hist. Brand 13 $6,613
Pentoxifylline Generic 28 $533
Triamcinolone Acetonide Generic 26 $489
Fluconazole Generic 13 $300
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 23 $206
Doxycycline Monohydrate Generic 14 $197
Cephalexin Generic 12 $173
Ketoconazole Generic 11 $132
Levofloxacin Generic 13 $98
Mupirocin Generic 15 $84

The 10 drugs with the highest cost, of 11 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 32 billing codes

Paid by Medicare

$65,342

Of which drugs: $29,045

Medicare patients

83

Average age 72

Services billed

861

40 women, 43 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Diabetes 58%
Arthritis 55%
Chronic kidney disease 54%
Heart failure 46%
Ischemic heart disease 42%
Depression 42%
Atrial fibrillation 33%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Grafix prime, grafixpl prime, stravix and stravixpl, per square centimeter Q4133 Office 12 271 $29,045

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

5 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner in Wisconsin

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record